CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 45 enrolled
Drug / intervention
sodium bicarbonatedrug
Likely dose
sodium bicarbonate 1950mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02502071
NCT02502071Phase 4Completed
CompareCT.gov

Effect of Urinary Alkalinization on Urine Uric Acid Precipitation and Crystallization in Adults With Type 1 DiabetesL a Open-label Trial

University of Colorado, Denver·interventional·Posted Jul 20, 2015·Updated Jun 17, 2026

In Brief

A Phase 4 clinical trial evaluating sodium bicarbonate for Type 1 Diabetes and 2 related conditions. Completed, enrolled 45 participants across 1 site.

Detailed Summary

The purpose of this study is to determine whether alkalinization of urine uric acid by 2 doses of sodium bicarbonate (1950mg) over 24-hours reduces precipitation and crystallization of urine uric acid over in adults with type 1 diabetes.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes, Diabetic Nephropathy, Diabetic Kidney Disease
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20162017201820192020202120222023202420252026
First PostedJul 20, 2015
Enrollment StartJan 1, 2017
Primary CompletionJul 1, 2017
Study CompletionAug 1, 2017
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 11.0 years ago

Interventions

sodium bicarbonatedrug

All participants will receive 2 doses of 1950mg sodium bicarbonate